INDIANA – Attorney General Todd Rokita is calling on the U.S. Environmental Protection Agency (EPA) to put tighter controls on the abortion-inducing drug mifepristone, which presents a growing threat to the U.S. population via chemically tainted medical waste being flushed into American waterways.
“Drug-induced abortions occurring outside of the legal, direct, and personal care of a properly licensed physician are causing pain and suffering to women,” Attorney General Rokita said. “Obviously, this starts with the individuals persuaded by Planned Parenthood and Big Pharma to use mifepristone to abort their pregnancies, but increasingly it extends to other women who might ingest the drug from their local water supplies.”
When a woman ingests mifepristone, it blocks her natural progesterone — thereby chemically destroying her baby’s uterine environment and preventing the baby from receiving nutrition. The baby, in effect, is starved to death in the womb.
As part of a 14-state coalition, Attorney General Rokita is requesting that the EPA add mifepristone to other pharmaceuticals included on the Contaminant Candidate List, which may lead to stricter regulation under the Safe Drinking Water Act.
“Over the last decade,” states the Missouri-led letter to the EPA, “the FDA has eliminated many of the protections that minimized the health risks posed by mifepristone and its approved generics, including the in-person dispensing and check-up requirements that kept medical staff involved in the process. Not only were the FDA’s changes to the REMS unlawful and unsafe, but the loosened regulations have also increased the number of chemical abortions occurring in the home, resulting in tons of chemically tainted medical waste being flushed into American waterways.”
If mifepristone reaches sufficient concentration, pregnant women who unintentionally ingest the drug through the public water supply could be at greater risk of health complications than the general population. In addition, recent research suggests that mifepristone can affect reproductive organ development and fertility.
Chemical abortions accounted for 63 percent of all U.S. abortions in the formal health care system as of 2023, compared to 31 percent in 2014 and 14 percent in 2005. These numbers do not include self-managed chemical abortions that occur when abortion providers mail mifepristone in violation of state law, which is also increasing.
The letter can be read in its entirety here.
